Symphony Financial Services’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,866
Closed -$32.1K 100
2025
Q4
$32.1K Sell
1,866
-14
-0.7% -$271 0.02% 102
2025
Q3
$48.4K Buy
1,880
+640
+52% +$24.2K 0.03% 96
2025
Q2
$71.3K Buy
1,240
+320
+35% +$25.7K 0.04% 89
2025
Q1
$99.6K Hold
920
0.07% 83
2024
Q4
$43.7K Buy
920
+282
+44% +$17K 0.04% 79
2024
Q3
$62.7K Hold
638
0.05% 80
2024
Q2
$96.3K Buy
+638
New +$90.9K 0.08% 83

Other funds holding AGL

Symphony Financial Services's AGL Position: Q1 2026 in Review

Symphony Financial Services sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 1,866 shares — an estimated $32.1K sold.

Symphony Financial Services first reported a position in AGL in Q2 2024 and held it in 7 quarters. The position peaked at $99.6K in Q1 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Symphony Financial Services reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Symphony Financial Services sold 1,866 Agilon Health shares in Q1 2026, an estimated $32.1K.
  • Symphony Financial Services first reported a position in Agilon Health in Q2 2024 and held it in 7 quarters.
  • Symphony Financial Services's Agilon Health position peaked at $99.6K in Q1 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Symphony Financial Services's 13F filing for Q1 2026, filed 7 May 2026.